Tsinghua Hosts APRU Provosts’ Forum 2022, Explores Futures of Higher Education
HONG KONG--(BUSINESS WIRE)--#HigherEducation--Tsinghua University hosted the Association of Pacific Rim Universities (APRU) Provosts’ Forum 2022…
4 years ago
Tsinghua Hosts APRU Provosts’ Forum 2022, Explores Futures of Higher Education
HONG KONG--(BUSINESS WIRE)--#HigherEducation--Tsinghua University hosted the Association of Pacific Rim Universities (APRU) Provosts’ Forum 2022…
4 years ago
VMware and Wipro Expand Partnership to Power Customers’ Digital Transformation
Companies extend decade-long partnership to help customers across industries realize value faster from app and…
4 years ago
VMware and Wipro Expand Partnership to Power Customers’ Digital Transformation
Companies extend decade-long partnership to help customers across industries realize value faster from app and…
4 years ago
Synchron Announces Enrollment of First Patient in U.S. Endovascular Brain Computer Interface Study COMMAND in Patients With Severe Paralysis
- Synchron and Mount Sinai Hospital in New York Advance Industry-First FDA-Approved Clinical Trial for…
4 years ago
VMware and Wipro Expand Partnership to Power Customers’ Digital Transformation
Companies extend decade-long partnership to help customers across industries realize value faster from app and…
4 years ago
Synchron Announces Enrollment of First Patient in U.S. Endovascular Brain Computer Interface Study COMMAND in Patients With Severe Paralysis
- Synchron and Mount Sinai Hospital in New York Advance Industry-First FDA-Approved Clinical Trial for…
4 years ago
Synchron Announces Enrollment of First Patient in U.S. Endovascular Brain Computer Interface Study COMMAND in Patients With Severe Paralysis
- Synchron and Mount Sinai Hospital in New York Advance Industry-First FDA-Approved Clinical Trial for…
4 years ago
OliX Pharmaceuticals Identifies Effective Inhibition of Target Gene Expression and Delivery of Candidate to Brain for CNS Therapeutics
SUWON, South Korea--(BUSINESS WIRE)--#AlzheimersDisease--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today…
4 years ago
Diamond Equity Research Releases Update Note on Medigus Limited (NASDAQ: MDGS)
NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research…
4 years ago